CNS

Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 134.47 M136.13 M141.72 M143.8 M145.64 M 567.29 M Gross profit 134.47 M136.13 M141.72 M143.8 M145.64 M 567.29 M Operating expenses 89.27 M92.8 M92.82 M103.49 M95.52 M 384.63 M Selling/general/admin expenses 17.17 M18.08 M16.77 M19.21 M18.9 M 72.97 M Research & development ————— — Operating income 45.2 M43.33 M48.9 M40.31 M50.12 M 182.66 M Non-Operating Income, Total 7.75 M10.51 M6.66 M1.98 M7.08 M 26.22 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 8.92 M13.03 M5.8 M2.97 M7.08 M 28.87 M Unusual income/expense -1.17 M-2.52 M859 K-991 K— — Pretax income 52.95 M53.83 M55.56 M42.29 M57.2 M 208.88 M Equity in earnings ————— — Taxes 5.71 M-2.23 M-1.49 M5.14 M7.86 M 9.28 M Non-controlling/minority interest 3.51 M4.92 M-77 K-4.18 M-1.15 M -478 K After tax other income/expense ————— — Net income before discontinued operations 39.78 M36.85 M41.71 M34.88 M42.37 M 155.81 M Discontinued operations ————— — Net income 39.78 M36.85 M41.71 M34.88 M42.37 M 155.81 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 39.78 M36.85 M41.71 M34.88 M42.37 M 155.81 M Basic earnings per share (Basic EPS) 0.780.720.810.680.82 3.03 Diluted earnings per share (Diluted EPS) 0.770.720.810.670.82 3.02 Average basic shares outstanding 51.06 M51.16 M51.2 M51.17 M51.44 M — Diluted shares outstanding 51.42 M51.47 M51.57 M51.53 M51.59 M — EBITDA 47.55 M45.7 M51.42 M42.84 M52.7 M 192.66 M EBIT 45.2 M43.33 M48.9 M40.31 M50.12 M 182.66 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 2.36 M2.38 M2.52 M2.54 M2.57 M 10 M